Approvals/TGA/FLIXOTIDE NEBULES fluticasone propionate 2.0mg/2mL inhalation ampoule

Approved

STANDARD

FLIXOTIDE NEBULES fluticasone propionate 2.0mg/2mL inhalation ampoule

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2e602ef975ba2531
Product Name: FLIXOTIDE NEBULES fluticasone propionate 2.0mg/2mL inhalation ampoule
Artg Id: 69002
Artg Name: FLIXOTIDE NEBULES fluticasone propionate 2.0mg/2mL inhalation ampoule
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 1999-05-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2838578e882b6a94dc4cdbac202c0ed9.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7b0cb39364a78dfcdfff71f569d741a7.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

2e602ef975ba2531

Type

Standard